Skip to main content
Clinical Trials/NCT06624501
NCT06624501
Completed
Not Applicable

Integrated Discovery and Development of Innovative TB Diagnostics

Harvard University Faculty of Medicine0 sites1,450 target enrollmentMay 1, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tuberculosis, Pulmonary
Sponsor
Harvard University Faculty of Medicine
Enrollment
1450
Primary Endpoint
Sensitivity for detection of Mtb, by sample type
Status
Completed
Last Updated
last year

Overview

Brief Summary

The long term goal of this project is to provide information critical to the development and use of a low-cost, point-of-care, rapid, simple, and highly accurate diagnostic tool that can help clinicians make a microbiological diagnosis in children who present with signs and symptoms suggestive of TB.

Specific aim 1: To identify the types of patient samples from which to best detect Mtb DNA in children with TB. We propose to obtain serial samples of sputum, blood, stool, and gastric and nasopharyngeal secretions from children with symptomatic TB and to use molecular methods to characterize the distribution of Mtb in these samples. The results of this study will allow us to identify the most promising sampling strategies for diagnosis of TB in children so that optimization of these easily-accessible samples for detection of Mtb nucleic acids can be addressed.

Specific aim 2: To determine whether cell free Mtb DNA can be detected in plasma and urine samples of children and adults with TB and to describe the host-related factors that alter the sensitivity of this assay. We propose to test serial urine and plasma samples for Mtb DNA fragments in two groups: (1) children with symptoms of TB and (2) adults with TB. Here, we will optimize sample volume sizes and of state-of-the-art sequencing tools to improve DNA recovery and detection. This study will help identify optimal samples and strategies for the non-invasive diagnosis of Mtb using urine.

Secondary aim: To create a bank of archived specimens for (1) optimization of Mtb DNA purification, extraction, and (2) use in future pediatric TB diagnostic research.

Registry
clinicaltrials.gov
Start Date
May 1, 2015
End Date
February 28, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Harvard University Faculty of Medicine
Responsible Party
Principal Investigator
Principal Investigator

Molly Franke

Assistant Professor of Global Health and Social Medicine

Harvard University Faculty of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Sensitivity for detection of Mtb, by sample type

Time Frame: Baseline

For each type of biologic specimen, the proportion of samples in which Mtb could be isolated by DNA detection methods (sensitivity) relative to the standard of care (a combination of sputum smear, sputum culture, signs and symptoms).

Similar Trials